Molecular Targets of Tannic Acid in Alzheimer's Disease

被引:39
|
作者
Braidy, Nady [1 ,2 ]
Jugder, Bat-Erdene [2 ]
Poljak, Anne [1 ,3 ]
Jayasena, Tharusha [1 ]
Nabavi, Seyed Mohammad [4 ]
Sachdev, Perminder [1 ,5 ]
Grant, Ross [3 ,6 ,7 ]
机构
[1] Univ New South Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia
[2] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia
[3] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia
[4] Baqiyatallah Univ Med Sci, Appl Biotechnol Res Ctr, Tehran, Iran
[5] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW, Australia
[6] Sydney Adventist Hosp, Australasian Res Inst, Sydney, NSW, Australia
[7] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Tannic acid; Alzheimer's disease; A beta pathology; tau; beta-secretase; neurons; AMYLOID PRECURSOR PROTEIN; MEMAPSIN-2; BETA-SECRETASE; DENDRITIC SPINE PATHOLOGY; GALLIC ACID; TAU-PROTEIN; COGNITIVE IMPAIRMENT; CEREBRAL-HEMORRHAGE; ACUTE TOXICITY; CELL BIOLOGY; HUMAN HEALTH;
D O I
10.2174/1567205014666170206163158
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Tannic acid (TA) is a naturally occurring plant-derived polyphenol found in several herbaceous and woody plants, including legumes, sorghum, beans, bananas, persimmons, rasberries, wines and a broad selection of teas. Clinically, TA has strong antioxidant/free radical scavenging, antiinflammatory, anti-viral/bacterial, and anti-carcinogenic properties. While the aetiology of Alzheimer's disease (AD) remains unclear, this complex multifactorial neurodegenerative disorder remains the most common form of dementia, and is a growing public health concern worldwide. The neuroprotective effects of TA against AD have been shown in several in vitro and in vivo models of AD. Apart from its potent antioxidant and anti-inflammatory roles, evidence suggests that TA is also a natural inhibitor of beta-secretase (BACE1) activity and protein expression. BACE1 is the primary enzyme responsible for the production and deposition of A beta peptide. TA also destabilises neurotoxic amyloid beta (A beta) fibrils in vitro. Apart from its effects on the A beta cascade, TA can also inhibit the in vitro aggregation of tau peptide, a core component of intracellular neurofibrillary tangles (NFTs). This review summarizes the relevance of TA and TA-related vegetable extracts (tannins) in the pathogenesis of AD and its enzymatic targets. It also highlights the significance of TA as an important lead compound against AD.
引用
收藏
页码:861 / 869
页数:9
相关论文
共 50 条
  • [41] Alzheimer's Disease Protein Targets: Comprehensive Review and Future Directions
    Kumar, Bandral Sunil
    Dinesh, Basavana Gowda Hosur
    Shajan, Sandra Ross Olakkengil
    Sadashivappa, Nandini Markuli
    Ammunje, Damodar Nayak
    Kunjiappan, Selvaraj
    Theivendren, Panneerselvam
    Pavadai, Parasuraman
    CURRENT PHARMACEUTICAL DESIGN, 2024,
  • [42] Caspases as Therapeutic Targets in Alzheimer's Disease: Is It Time to "Cut" to the Chase?
    Rohn, Troy T.
    Head, Elizabeth
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2009, 2 (02): : 108 - 118
  • [43] Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer's Disease
    Eysert, Fanny
    Kinoshita, Paula Fernanda
    Mary, Arnaud
    Vaillant-Beuchot, Loan
    Checler, Frederic
    Chami, Mounia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 29
  • [44] Emerging drug targets for A and tau in Alzheimer's disease: a systematic review
    West, Sophie
    Bhugra, Praveen
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (02) : 221 - 234
  • [45] Effect of Lycoris chejuensis and Its Active Components on Experimental Models of Alzheimer's Disease
    Kim, Joonki
    Park, Yurim
    Chun, Yoon Sun
    Cha, Jin Wook
    Kwon, Hak Cheol
    Oh, Myung Sook
    Chung, Sungkwon
    Yang, Hyun Ok
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2015, 63 (31) : 6979 - 6988
  • [46] Iron dyshomeostasis and ferroptosis in Alzheimer's disease: Molecular mechanisms of cell death and novel therapeutic drugs and targets for AD
    Zhang, Yuan
    Wang, Man
    Chang, Wenguang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [47] The molecular mechanism, targets, and novel molecules in the treatment of Alzheimer's disease
    Verma, Akash
    Waiker, Digambar Kumar
    Bhardwaj, Bhagwati
    Saraf, Poorvi K.
    Shrivastava, Sushant
    BIOORGANIC CHEMISTRY, 2022, 119
  • [48] Alzheimer's disease, enzyme targets and drug discovery struggles: From natural products to drug prototypes
    Silva, Tiago
    Reis, Joana
    Teixeira, Jose
    Borges, Fernanda
    AGEING RESEARCH REVIEWS, 2014, 15 : 116 - 145
  • [49] Brain ischemia with Alzheimer phenotype dysregulates Alzheimer's disease-related proteins
    Ulamek-Koziol, Marzena
    Pluta, Ryszard
    Bogucka-Kocka, Anna
    Januszewski, Slawomir
    Kocki, Janusz
    Czuczwar, Stanislaw J.
    PHARMACOLOGICAL REPORTS, 2016, 68 (03) : 582 - 591
  • [50] Neuropathological Mechanisms Associated with Pesticides in Alzheimer's Disease
    Tang, Bor Luen
    TOXICS, 2020, 8 (02)